Editorial: We may need large trials to find treatments for neurodegenerative diseases

被引：0

作者：

Schoenfeld, David Alan ^{[1
]}

Benatar, Michael ^{[2
]}

机构：

[1] Massachusetts Gen Hosp, Biostat Ctr, 50 Staniford St, Boston, MA 02114 USA

[2] Univ Miami, Miller Sch Med, Miami, FL 33136 USA

来源：

CLINICAL TRIALS | 2019年 / 16卷 / 02期

关键词：

Alzheimer's disease; ALS; Parkinson's disease; clinical trials; sample size;

D O I：

10.1177/1740774518820814

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：120 / 121

页数：2

共 9 条

[1]

[Anonymous], BMJ BRIT MED J

[2] Preventing familial amyotrophic lateral sclerosis: Is a clinical trial feasible? [J].

Benatar, Michael ;

Polak, Meraida ;

Kaplan, Samantha ;

Glass, Jonathan .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 251 (1-2) :3-9

[3] Presymptomatic studies in ALS Rationale, challenges, and approach [J].

Benatar, Michael ;

Wuu, Joanne .

NEUROLOGY, 2012, 79 (16) :1732-1739

[4]

Brookmeyer R, CLIN TRIALS

[5] Disease-modifying therapies for Alzheimer disease [J].

Cummings, Jeffrey L. ;

Doody, Rachelle ;

Clark, Christopher .

NEUROLOGY, 2007, 69 (16) :1622-1634

[6] FINAL REPORT ON THE ASPIRIN COMPONENT OF THE ONGOING PHYSICIANS HEALTH STUDY [J].

HENNEKENS, CH .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (03) :129-135

[7]

Meek PD, 1998, PHARMACOTHERAPY, V18, P68

[8] A calculated risk: the Salk polio vaccine field trials of 1954 [J].

Meldrum, M .

BRITISH MEDICAL JOURNAL, 1998, 317 (7167) :1233-1236

[9] The prediagnostic phase of Parkinson's disease [J].

Noyce, Alastair John ;

Lees, Andrew John ;

Schrag, Anette-Eleonore .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (08) :871-878

← 1 →